| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.005 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |